ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ChemDiv Forges Strategic Partnership with The University of Texas Medical Branch (UTMB) to Expand Its High-throughput Screening Research Capabilities

SAN DIEGO, Dec. 28, 2023 /PRNewswire/ — ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the expansion of its inventory and […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Fresh Start Surgical Gifts Celebrates a Year of Compassionate Care, Community Impact and Transformative Milestones, Looking Ahead to 2024

SAN DIEGO, Dec. 27, 2023 /PRNewswire/ — As we bid farewell to another transformative year, national nonprofit Fresh Start Surgical Gifts proudly reflects on its significant accomplishments in 2023. With a steadfast commitment to providing […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

TAIPEI and SAN DIEGO, Dec. 26, 2023 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that Taiwan Food and […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

Experts Gather at SDSC to Discuss Using Data and AI to Improve Responses to Mass Casualty Events

Computer science and AI researchers, school safety managers, 911 program directors, service providers and policymakers discussed using 911 data streams with advanced AI models to improve response to mass casualty events, especially on school campuses. […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics

SAN DIEGO & SINGAPORE–(BUSINESS WIRE)–The collaboration aims to produce off-the-shelf TCR-based bispecific molecules that could lead to more effective treatments for solid tumors. Click here to view original post

News

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced an update on multi-cytokine programs EQ101 in development for […]

No Picture
News

CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster

KING OF PRUSSIA, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious Diseases of a Phase 3 study showing that […]